5 News & Press Releases found
Cellphire Therapeutics, Inc. News
-
Cellphire Therapeutics Appoints Roy A. Beveridge, M.D. to Scientific Advisory Board
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Roy A. Beveridge, M.D. to the company’s ...
-
Cellphire Therapeutics Names W. Allan Alexander, MD as Chief Medical Officer
Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic cellular therapeutics announced today the appointment of W. Allan Alexander, MD as the company’s Chief Medical Officer, effective ...
-
Cellphire Therapeutics Appoints Pamela B. Conley to its Board of Directors
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Pamela B. Conley, Ph.D. to the company’s ...
-
Cellphire Therapeutics Names Angie Howerton as Vice President of Finance, Controller and Treasurer
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today that Angie Howerton, CPA, has joined the company as Vice President ...
-
Cellphire Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Thrombosomes in Bleeding Thrombocytopenic Patients
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company’s ...